tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
Advertisement

Simcere Pharmaceutical Group Limited (2096) Similar Stocks

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Simcere Pharmaceutical Group Limited
HK$14.12
HK$34.94B
36.58
144.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$17.45
HK$25.26B
252.53%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$32.98
HK$45.72B
203.68%
1 Buy
0 Hold
1 Sell
Hold
Everest Medicines Ltd.
HK$64.35
HK$22.30B
194.51%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Henlius Biotech, Inc. Class H
HK$77.90
HK$42.34B
47.57
247.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$83.25
HK$30.67B
145.21%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2096
Simcere Pharmaceutical Group Limited
14.08
8.33
144.87%
HK:9969
InnoCare Pharma Ltd.
17.45
12.50
252.53%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
32.98
22.12
203.68%
HK:1952
Everest Medicines Ltd.
64.35
42.50
194.51%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
80.00
56.95
247.07%
HK:6855
Ascentage Pharma Group International
83.25
49.30
145.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis